Insider · CIK 0001172346
Michael D Dale
ceoofficer
Files at AXGN (Axogen, Inc.). First filing Dec 10, 2025, latest Dec 12, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $2.7M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AXGN: Axogen, Inc.
AXGNOct 9, 2026 · close 36.13
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 72Notable | Axogen, Inc. | $750k 25,000 shares | -28% | +223% from low-10% from high | |
| 75Notable | Axogen, Inc. | $1.9M 61,463 shares | -41% | +229% from low-8% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -25,000 | $30.00 | $750k | 63,537 | Dec 12, 2025 |
| Dec 9, 2025 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -61,463 | $31.21 | $1.9M | 88,537 | Dec 10, 2025 |
| Dec 4, 2025 | AXGN Axogen, Inc. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 150,000 | Dec 5, 2025 |
| Mar 25, 2025 | AXGN Axogen, Inc. | AGrant or award Restricted Stock Unitsderivative | +176,300 | $0.00 | $0 | 176,300 | Mar 26, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.